Leveraging the deep bench strength of its global network of 70 offices across North America, Latin America, and the EMEA and Asia Pacific regions, the Toronto corporate team of Baker McKenzie advises domestic and multinational corporates on high-value, cross-border transactions. With a client base spanning such sectors as pharmaceuticals, chemicals, aerospace, engineering, professional services and healthcare, the practice's full offering covers M&A, restructurings, takeover bids and corporate reorganizations. The team is led by David Palumbo, who brings expertise to capital markets and public M&A matters, along with Nancy Hamzo, a specialist in complex life sciences and tech industry transactions. Another name to note is Haran Viswanathan, who was promoted to partner in January 2024.
Testimonials
Collated independently by Legal 500 research team.
‘We've worked with the Baker McKenzie M&A team on a number of transactions and appreciate the partner attention and continuity of a smaller team deal after deal. Team is diverse and led by a female partner.’
‘Nancy Hamzo is amazing - really trust her as deal lead and she keeps a strong, dedicated team.'
‘The team are very commercial in their advice, factoring in their knowledge of our business and its values, objectives and challenges - more importantly however, they invest in understanding those aspects through both committing time and resources to build relationships with our internal team, our business and how we do things.’
‘Long-standing commitment to client service over almost 20 years, very responsive, continually demonstrating that we are not simply another client, despite being a small client in their portfolio.’
Key clients
- NeuPath Health
- Bloom Burton Securities
- Flowserve Corporation
- Dexterra Group
- New Mountain Capital
- Thomson Reuters
- Afry AB
- Regeneron Pharmaceuticals
- Johnson & Johnson
- Safran
Work highlights
- Advised NeuPath Health, a provider of chronic pain management services, in the acquisition of London Spine Clinic, a pain, spine and sport medicine clinic located in Ontario.
- Advised Bloom Burton Securities, as lead agent, in connection with the short form prospectus equity offering of 110m units of Satellos Bioscience, a regenerative medicine company listed on the TSXV, for aggregate gross proceeds of C$55 million.
- Advised Flowserve Corporation in its definitive agreement to acquire Velan in an all-cash transaction valued at approx. $245 million, including the purchase of all issued and outstanding equity, the assumption of debt and other assets.
Lawyers
Practice head
The lawyer(s) leading their teams.
David Palumbo, Nancy Hamzo